After a century of failed policies and “canna-bigotry,” the verdict is in. Legalization is a success, and the end of cannabis prohibition can’t come soon enough.
Tag: psychosis
Republican lawmakers are seeking to preemptively restrict Florida’s adult-use market ahead of the Court’s ruling and before voters have had any opportunity to weigh in on it.
“Canada’s real-world experience with marijuana legalization … affirms that these policies can be implemented in a way that provides regulated access for adults while simultaneously limiting youth access, discouraging misuse, and not compromising public safety.”
The establishment of a regulated market designed to keep cannabis products away from young people, and that provides clear warnings to those specific populations who may be more vulnerable to its effects — coupled with a policy of consumer education — is the best way to protect public health and mitigate consumers’ risks.
Investigators concluded, “High potency cannabis use, measured as THC concentration in cannabis and high potency cannabis preference, was not associated with increased symptoms of psychosis.”
“This study is the … largest … to quantify the association of medical and recreational cannabis policies with rates of psychosis-related health care claims across US states. … [W]e did not observe a statistically significant association of state cannabis policy level with overall rates of psychosis-related diagnoses or prescribed antipsychotics.”
A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk.
The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry.